Tag: STAT news

9/13/2017

STAT becomes 3rd major organization to revise policies after our scrutiny

2 9/12/2017

Another ‘breach of trust’ at STAT: patient who praised TV drug ads says pharma PR company asked her to write op-ed

5 9/7/2017

‘A blow to [STAT’s] credibility’: MD listed as author of op-ed praising drug reps didn’t write it. Ghostwriting/PR influence

3 9/5/2017

Tone deaf again on pharma conflict of interest: STAT piece praising drug reps fails to disclose industry payments

7 6/12/2017

Conflicts of interest in health care journalism. Who’s watching the watchdogs? We are. Part 1 of 3

3 12/14/2016

Is STAT tone-deaf in accepting PhRMA sponsorship?

3 6/22/2016

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

6/13/2016

21st Century Cures Act nears passage with little news media scrutiny

5/27/2016

5-Star Friday! Not a cancer ‘cure,’ a menstrual pain ‘off switch,’ and therapy for ‘text neck’

5 5/17/2016

Why “exercise lowers cancer risk” headlines mislead readers